Medication Considerations

An informational page on the Bloomberg American Health Initiative website which details facts and resources from their Fentanyl Overdose Reduction Checking Analysis Study (FORECAST).

A factsheet about the dangers of polysubstance use.

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

A comprehensive household interview survey of substance use, substance use disorders, mental health, and the receipt of treatment services for these disorders in the United States.

A toolkit to promote the overall health and well-being of pregnant people who use substances and their families.

A core curriculum training package to provide information about central nervous system stimulants and their impact on brain, body, and behavior.

This brief describes research documenting the added challenges stimulant use contributes to those who use opioids and patient-centered approaches for working with people who use stimulants that are enrolled in medication treatment for opioid use disorder.

These guidelines provide eligible clinicians who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services.

This paper offers principle and recommendations for remediating the impacts of the rising rates of drugs adulterated or laced with fentanyl.

One of SAMHSA's series of advisories based on TIP 49, which provides an overview of medications for treatment of alcohol use disorder